Advertisement
Screener

INMUNE BIO INC. (INMB) Form D

INMUNE BIO INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2019-05-10: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-04-29; Total offering amount $4,699,904.
  • 2017-07-13: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-03-15; Total offering amount $5,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2019-05-10Rule 506(b)Equity2019-04-29$4,699,904$4,699,904$05
2017-07-13Rule 506(b)Equity2017-03-15$5,000,000$3,340,000$1,660,00029

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B